Literature DB >> 6350462

Expression of antibody activity measured by ELISA. Anti-ssDNA antibody activity characterized by the shape of the dose-response curve.

M Gripenberg, G Gripenberg.   

Abstract

To demonstrate the presence or absence of antibodies, results derived from a single serum dilution in an ELISA are sufficient. However, qualitative differences in antibodies are reflected by the shape of dose-response curves. A method based on approximating the absorbance value by a polynomial p(x) = a1x + a2x2, where 1/x is the dilution factor, was used to characterize the dose-response curves in an ELISA for anti=ssDNA antibodies. The parameters used are E = a1 and A = -a2(1)/a2. It can be argues that E gives an estimate of the effective amount of antibodies in the serum and that A is essentially a function of the reaction constants between antibody and antigen.

Mesh:

Substances:

Year:  1983        PMID: 6350462     DOI: 10.1016/0022-1759(83)90175-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Quantitation of indirect sandwich enzyme-linked immunosorbent assay parameters.

Authors:  R R Chalquest
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

2.  Amount and Avidity of IgG Antibodies to Pseudomonas Aeruginosa Exotoxin A Antigen in Cystic Fibrosis Patients.

Authors:  Janja Polanec; Jan Patzer; Jacek Grzybowski; Milan Strukelj; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

3.  Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; M Leirisalo; E Johansson; G Gripenberg
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

4.  Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.

Authors:  J Grzybowski; E A Trafny; J Wrembel-Wargocka; J Patzer; D Dzierzanowska; I Zawistowska-Marciniak; M Kłos
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 11.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.